. . "9" . "8"^^ . "Fila, Libor" . . "RIV/00064203:_____/10:6411!RIV11-MZ0-00064203" . . . "Lung Transplantation in Cystic Fibrosis Patients in the Czech Republic: Initial Single-Center Experience" . . . . . . "Lung Transplantation in Cystic Fibrosis Patients in the Czech Republic: Initial Single-Center Experience" . . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . . . "RIV/00064203:_____/10:6411" . "Mal\u00FD, M." . "Lischke, Robert" . "I, Z(MZ0FNM2005)" . . "42" . "Burkert, Jan" . "cystick\u00E1 fibr\u00F3za; Burkholderia cepacia; \u010Dekac\u00ED listina; plicn\u00ED transplantace"@en . "Lung Transplantation in Cystic Fibrosis Patients in the Czech Republic: Initial Single-Center Experience"@en . "269041" . . . "Lung transplantation (LuTx) is a well established treatment for advanced lung diseases. We compared the clinical results of patients with cystic fibrosis (CF) entered into the waiting list (WL) with those of patients after LuTx. Among 36 patients with CF on the WL, 23 underwent LuTx, 8 died, 3 are still on WL, and 2 were excluded from WL. The median WL time of 0.48 years (range, 0.03-2.37) was insignificantly longer for patients who died compared with transplanted patients (0.97 vs 0.44 years). Mortality of WL patients was 25.8%. The median survival of transplant patients of 7.48 years (range 0.00-10.85 years) was significantly lower among patients who were colonized with Burkholderia cepacia complex (BCC) versus those who were not colonized (0.19 vs 7.48 years; P = .041). The 1-, 3-, and 5-year patient survivals after LuTx were 72.9, 54.4, and 54.4, respectively. The results of patients with CF on WL versus after LuTx in our center were similar to those reported in the literature."@en . "4"^^ . "\u0160imonek, Jan" . . "0041-1345" . "Lung Transplantation in Cystic Fibrosis Patients in the Czech Republic: Initial Single-Center Experience"@en . "000284969800067" . "Transplantation Proceedings" . "Lung transplantation (LuTx) is a well established treatment for advanced lung diseases. We compared the clinical results of patients with cystic fibrosis (CF) entered into the waiting list (WL) with those of patients after LuTx. Among 36 patients with CF on the WL, 23 underwent LuTx, 8 died, 3 are still on WL, and 2 were excluded from WL. The median WL time of 0.48 years (range, 0.03-2.37) was insignificantly longer for patients who died compared with transplanted patients (0.97 vs 0.44 years). Mortality of WL patients was 25.8%. The median survival of transplant patients of 7.48 years (range 0.00-10.85 years) was significantly lower among patients who were colonized with Burkholderia cepacia complex (BCC) versus those who were not colonized (0.19 vs 7.48 years; P = .041). The 1-, 3-, and 5-year patient survivals after LuTx were 72.9, 54.4, and 54.4, respectively. The results of patients with CF on WL versus after LuTx in our center were similar to those reported in the literature." . . "3"^^ . . "Ad\u00E1mek, S." . "[ACE4BC55B8F2]" . "Pozniak, J." . "Valentov\u00E1 Bart\u00E1kov\u00E1, L." . .